Comparison between Gabion Technologies IPO and Modern Diagnostic IPO.
Gabion Technologies IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Modern Diagnostic IPO is a SME Bookbuilding proposed to list at BSE SME.
| Gabion Technologies IPO | Modern Diagnostic IPO | |
|---|---|---|
| Logo | ![]() | ![]() |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | GYR Capital Advisors Pvt.Ltd. | Beeline Capital Advisors Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Giriraj Stock Broking Pvt.Ltd. | Spread X Securities Pvt.Ltd. |
| DRHP | DRHP ![]() | DRHP ![]() |
| RHP | RHP ![]() | RHP ![]() |
| Final Prospectus | Final Prospectus ![]() | Final Prospectus ![]() |
| Anchor Investor | Anchor Investor ![]() | Anchor Investor ![]() |
| IPO Allotment URL | IPO Allotment URL ![]() | IPO Allotment URL ![]() |
The total issue size of Gabion Technologies IPO is up to ₹27.70 Cr whereas the issue size of the Modern Diagnostic IPO is up to ₹35.04 Cr. The final issue price of Gabion Technologies IPO is ₹81.00 per share and of Modern Diagnostic IPO is ₹90.00 per share.
| Gabion Technologies IPO | Modern Diagnostic IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹76.00 per share | ₹85.00 per share |
| Issue Price (Upper) | ₹81.00 per share | ₹90.00 per share |
| Issue Price (Final) | ₹81.00 per share | ₹90.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1600 shares |
| Fresh Issue Size | 34,19,200 shares | 38,92,800 shares |
| Fresh Issue Size (Amount) | up to ₹27.70 Cr | up to ₹35.04 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 34,19,200 shares | 38,92,800 shares |
| Issue Size Total (Amount) | up to ₹27.70 Cr | up to ₹35.04 Cr |
Gabion Technologies IPO opens on Jan 06, 2026, while Modern Diagnostic IPO opens on Dec 31, 2025. The closing date of Gabion Technologies IPO and Modern Diagnostic IPO is Jan 08, 2026, and Jan 02, 2026, respectively.
| Gabion Technologies IPO | Modern Diagnostic IPO | |
|---|---|---|
| Anchor Bid Date | Jan 05, 2026 | Dec 30, 2025 |
| Issue Open | Jan 06, 2026 | Dec 31, 2025 |
| Issue Close | Jan 08, 2026 | Jan 02, 2026 |
| Basis Of Allotment (Tentative) | Jan 09, 2026 | Jan 05, 2026 |
| Initiation of Refunds (Tentative) | Jan 12, 2026 | Jan 06, 2026 |
| Credit of Share (Tentative) | Jan 12, 2026 | Jan 06, 2026 |
| Listing date (Tentative) | Jan 13, 2026 | Jan 07, 2026 |
| Anchor Lockin End date 1 | Feb 07, 2026 | Feb 03, 2026 |
| Anchor Lockin End date 2 | Apr 08, 2026 | Apr 04, 2026 |
Gabion Technologies IPO P/E ratio is 12.18, as compared to Modern Diagnostic IPO P/E ratio of 11.04.
| Gabion Technologies IPO | Modern Diagnostic IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Gabion Technologies India Ltd.'s revenue decreased by 4% and profit after tax (PAT) rose by 14% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Modern Diagnostic & Research Centre Ltd.'s revenue increased by 15% and profit after tax (PAT) rose by 55% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 99.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.47 | 72.85 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.18 | 11.04 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹109.96 Cr. | ₹135.89 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 55.21 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 19.17 | 36.18 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.12 | 1.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.65 | ₹8.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 30.05 | 43.27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Gabion Technologies IPO Retail Individual Investors (RII) are offered 12,00,000 shares while in Modern Diagnostic IPO retail investors are offered 12,00,000 shares. Qualified Institutional Buyers (QIB) are offered 6,83,200 shares in Gabion Technologies IPO and 7,82,400 shares in Modern Diagnostic IPO.
| Gabion Technologies IPO | Modern Diagnostic IPO | |
|---|---|---|
| Anchor Investor Reservation | 10,22,400 shares | 11,61,600 shares |
| Market Maker Reservation | 1,80,800 shares | 2,06,400 shares |
| QIB | 6,83,200 shares | 7,82,400 shares |
| NII | 5,13,600 shares | 5,85,600 shares |
| RII | 12,00,000 shares | 13,63,200 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 34,19,200 shares | 38,92,800 shares |
Gabion Technologies IPO subscribed 826.00x in total, whereas Modern Diagnostic IPO subscribed 376.90x.
| Gabion Technologies IPO | Modern Diagnostic IPO | |
|---|---|---|
| QIB (times) | 271.13x | 193.51x |
| NII (times) | 1,467.78x | 702.08x |
| Big NII (times) | 1,780.71x | 855.83x |
| Small NII (times) | 841.91x | 386.91x |
| RII (times) | 867.23x | 342.46x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 826.00x | 376.90x |